163 related articles for article (PubMed ID: 19331151)
21. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of tissue microarrays.
Simon R; Mirlacher M; Sauter G
Methods Mol Biol; 2010; 664():113-26. PubMed ID: 20690058
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
[TBL] [Abstract][Full Text] [Related]
24. Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.
Wärnberg F; Amini RM; Goldman M; Jirström K
Histopathology; 2008 Dec; 53(6):642-9. PubMed ID: 19076680
[TBL] [Abstract][Full Text] [Related]
25. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
26. DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer.
Yamashita S; Chujo M; Moroga T; Anami K; Tokuishi K; Miyawaki M; Kawano Y; Takeno S; Yamamoto S; Kawahara K
Anticancer Res; 2009 Jul; 29(7):2753-7. PubMed ID: 19596956
[TBL] [Abstract][Full Text] [Related]
27. Tissue microarray studies in bladder cancer.
Hartmann A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):141-6. PubMed ID: 18815928
[TBL] [Abstract][Full Text] [Related]
28. Mouse spleen tissue as a staining intensity reference for immunohistochemistry.
Moon Y; Park G; Han K; Kang CS; Lee W
Ann Clin Lab Sci; 2008; 38(3):215-20. PubMed ID: 18715848
[TBL] [Abstract][Full Text] [Related]
29. HER2/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens.
Lesnikova I; Lidang M; Hamilton-Dutoit S; Koch J
APMIS; 2009 Oct; 117(10):737-45. PubMed ID: 19775342
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
[TBL] [Abstract][Full Text] [Related]
31. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Camp RL; Neumeister V; Rimm DL
J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
[TBL] [Abstract][Full Text] [Related]
32. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
33. Miniature tissue microarrays for HercepTest standardisation and analysis.
Gulmann C; Loring P; O'Grady A; Kay E
J Clin Pathol; 2004 Nov; 57(11):1229-31. PubMed ID: 15509692
[TBL] [Abstract][Full Text] [Related]
34. Robust gridding of TMAs after whole-slide imaging using template matching.
Lahrmann B; Halama N; Westphal K; Ernst C; Elsawaf Z; Sinn P; Bosch FX; Dickhaus H; Jäger D; Schirmacher P; Grabe N
Cytometry A; 2010 Dec; 77(12):1169-76. PubMed ID: 20662092
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma.
Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H
Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170
[TBL] [Abstract][Full Text] [Related]
36. HER-2/neu analysis in breast cancer bone metastases.
Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
[TBL] [Abstract][Full Text] [Related]
37. High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.
Hammer AS; Williams B; Dietz HH; Hamilton-Dutoit SJ
Vet Pathol; 2007 Mar; 44(2):196-203. PubMed ID: 17317796
[TBL] [Abstract][Full Text] [Related]
38. Comparison of apolipoprotein D determination methods in breast cancer.
Søiland H; Skaland I; Janssen EA; Gudlaugsson E; Körner H; Varhaug JE; Søreide JA; Baak JP
Anticancer Res; 2008; 28(2B):1151-60. PubMed ID: 18505051
[TBL] [Abstract][Full Text] [Related]
39. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
40. Limitations of tissue micro array in Duke's B colon cancer.
Kjaer-Frifeldt S; Lindebjerg J; Brünner N; Garm Spindler KL; Jakobsen A
APMIS; 2012 Oct; 120(10):819-27. PubMed ID: 22958290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]